Healing of perineal Crohn's disease with metronidazole

L. H. Bernstein, M. S. Frank, Lawrence J. Brandt, Scott J. Boley

Research output: Contribution to journalArticle

281 Citations (Scopus)

Abstract

The effect of metronidazole was studied in 21 consecutive patients with chronic unremitting perineal Crohn's disease. Drainage, erythema, and induration diminished dramatically in all patients, and complete healing was obtained in 10 of 18 patients maintained on therapy. Five others have shown advanced healing; in 2 patients the inflammation is improved, but healing is minimal. Side effects of metallic taste, dark urine, and mild gastrointestinal upset occurred in many patients. However, the dosage had to be decreased in only 4 patients and the drug discontinued in only 1 patient, all because of peripheral neuropathy that proved to be reversible. In 2 other patients, metronidazole was discontinued because of poor compliance. If further experience corroborates this prompt and striking response in patients with extreme, disabling, and otherwise unmanageable disease, metronidazole will play an important role in the therapy of perineal Crohn's disease.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalGastroenterology
Volume79
Issue number2
StatePublished - 1980

Fingerprint

Metronidazole
Crohn Disease
Taste Disorders
Peripheral Nervous System Diseases
Erythema
Drainage
Urine
Inflammation
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Healing of perineal Crohn's disease with metronidazole. / Bernstein, L. H.; Frank, M. S.; Brandt, Lawrence J.; Boley, Scott J.

In: Gastroenterology, Vol. 79, No. 2, 1980, p. 357-365.

Research output: Contribution to journalArticle

Bernstein, LH, Frank, MS, Brandt, LJ & Boley, SJ 1980, 'Healing of perineal Crohn's disease with metronidazole', Gastroenterology, vol. 79, no. 2, pp. 357-365.
Bernstein, L. H. ; Frank, M. S. ; Brandt, Lawrence J. ; Boley, Scott J. / Healing of perineal Crohn's disease with metronidazole. In: Gastroenterology. 1980 ; Vol. 79, No. 2. pp. 357-365.
@article{927d8cd2359d46939004535fd3365c67,
title = "Healing of perineal Crohn's disease with metronidazole",
abstract = "The effect of metronidazole was studied in 21 consecutive patients with chronic unremitting perineal Crohn's disease. Drainage, erythema, and induration diminished dramatically in all patients, and complete healing was obtained in 10 of 18 patients maintained on therapy. Five others have shown advanced healing; in 2 patients the inflammation is improved, but healing is minimal. Side effects of metallic taste, dark urine, and mild gastrointestinal upset occurred in many patients. However, the dosage had to be decreased in only 4 patients and the drug discontinued in only 1 patient, all because of peripheral neuropathy that proved to be reversible. In 2 other patients, metronidazole was discontinued because of poor compliance. If further experience corroborates this prompt and striking response in patients with extreme, disabling, and otherwise unmanageable disease, metronidazole will play an important role in the therapy of perineal Crohn's disease.",
author = "Bernstein, {L. H.} and Frank, {M. S.} and Brandt, {Lawrence J.} and Boley, {Scott J.}",
year = "1980",
language = "English (US)",
volume = "79",
pages = "357--365",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Healing of perineal Crohn's disease with metronidazole

AU - Bernstein, L. H.

AU - Frank, M. S.

AU - Brandt, Lawrence J.

AU - Boley, Scott J.

PY - 1980

Y1 - 1980

N2 - The effect of metronidazole was studied in 21 consecutive patients with chronic unremitting perineal Crohn's disease. Drainage, erythema, and induration diminished dramatically in all patients, and complete healing was obtained in 10 of 18 patients maintained on therapy. Five others have shown advanced healing; in 2 patients the inflammation is improved, but healing is minimal. Side effects of metallic taste, dark urine, and mild gastrointestinal upset occurred in many patients. However, the dosage had to be decreased in only 4 patients and the drug discontinued in only 1 patient, all because of peripheral neuropathy that proved to be reversible. In 2 other patients, metronidazole was discontinued because of poor compliance. If further experience corroborates this prompt and striking response in patients with extreme, disabling, and otherwise unmanageable disease, metronidazole will play an important role in the therapy of perineal Crohn's disease.

AB - The effect of metronidazole was studied in 21 consecutive patients with chronic unremitting perineal Crohn's disease. Drainage, erythema, and induration diminished dramatically in all patients, and complete healing was obtained in 10 of 18 patients maintained on therapy. Five others have shown advanced healing; in 2 patients the inflammation is improved, but healing is minimal. Side effects of metallic taste, dark urine, and mild gastrointestinal upset occurred in many patients. However, the dosage had to be decreased in only 4 patients and the drug discontinued in only 1 patient, all because of peripheral neuropathy that proved to be reversible. In 2 other patients, metronidazole was discontinued because of poor compliance. If further experience corroborates this prompt and striking response in patients with extreme, disabling, and otherwise unmanageable disease, metronidazole will play an important role in the therapy of perineal Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=0018967012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018967012&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 357

EP - 365

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -